Page last updated: 2024-09-03

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Thyroid Neoplasms

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with Thyroid Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jóźwiak, P; Krześlak, A; Lipińska, A1

Other Studies

1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Thyroid Neoplasms

ArticleYear
Down-regulation of β-N-acetyl-D-glucosaminidase increases Akt1 activity in thyroid anaplastic cancer cells.
    Oncology reports, 2011, Volume: 26, Issue:3

    Topics: Acetylglucosamine; beta-N-Acetylhexosaminidases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Insulin-Like Growth Factor I; Oximes; Phenylcarbamates; Phosphorylation; Proto-Oncogene Proteins c-akt; RNA Interference; Thyroid Neoplasms

2011